Published: July 2025 | Last updated: April 2026
The story of sexually transmitted diseases is older than the words we use to name them. Egyptian physicians described painful urethral discharges 3,500 years ago. Hippocrates wrote about a wasting urinary illness that reads, to a modern eye, like advanced gonorrhea. Cleopatra is wrapped in legend, but the medicine of her era already understood that some illnesses moved through sex. Then Renaissance Europe was hit by the Great Pox, and the modern era of STD panic, treatment, and stigma began in earnest. This piece traces that long arc: where these infections came from, how each century tried (and often failed) to handle them, and what the arc tells us about getting tested today.
How long have STDs been part of human history?
Sexually transmitted infections appear in the medical record as far back as ancient Egypt and Greece, with recognizable descriptions of gonorrhea-like illness in 5th-century BCE Greek texts. Syphilis erupted across Europe after the 1494 siege of Naples, with genetic evidence linking it to the Columbian Exchange. Treatments stayed brutal (mercury, arsenic, bloodletting) until Salvarsan in 1910 and penicillin in the 1940s. Today, despite modern antibiotics, the WHO and CDC report that syphilis and gonorrhea are resurging, and the WHO has placed cephalosporin-resistant Neisseria gonorrhoeae on its high-priority list of bacteria for which new antibiotics are urgently needed.
Ancient origins: bones, papyri, and the earliest hints
The first physical evidence of sexually transmitted disease predates writing. Paleopathologists have identified bone lesions consistent with treponemal disease (the family that includes syphilis) in skeletal remains from prehistoric humans on multiple continents. By the time of Cleopatra, ancient Egyptian medical papyri, including the Ebers and Kahun documents, already described conditions that look strikingly like genital ulcers, urethritis, and pelvic inflammatory disease, even if the writers attributed them to sorcery, divine punishment, or imbalanced humors rather than microbes.
There is no medical proof that Cleopatra herself had an STD. The legends say more about how later eras imagined powerful women than about her actual health. What is documented is that her contemporaries were already using physical barriers (animal-intestine sheaths, plant-fiber pessaries) for both contraception and crude infection control, and that healers in Alexandria, Athens, and Rome were comparing notes on a class of "shameful" illnesses that traveled with sex. The vocabulary was wrong, but the pattern recognition was real.
Hippocrates and the Greco-Roman record
Around 400 BCE, Hippocrates wrote about a urinary condition involving discharge and pain that most modern historians read as gonorrhea. The Roman encyclopedist Celsus, writing in the 1st century CE, catalogued ulcerative genital lesions and inflammation that line up with what we would now call chancres, herpes, and chancroid. Galen, the most influential physician of late antiquity, described "unnatural fluxes" of the urethra and prescribed everything from cooling herbs to surgical cauterization.
None of these writers had the concept of a microbe. Sexual disease was filed under skin disease, urinary disease, or moral disease, depending on the writer. Venereology as a defined specialty would not exist for another 1,800 years. Still, the Greco-Roman record establishes something important: across the Mediterranean world, physicians already knew that some illnesses preferentially moved through sexual contact, and they already noticed that women bore a heavier diagnostic and social burden for these illnesses than men.
Treponemal bone lesions (the kind associated with the syphilis family of bacteria) have been documented in pre-Columbian skeletal remains from sites in North and South America, and similar but milder lesions appear in some pre-1492 European remains. This is part of why historians describe the post-1494 European epidemic as a likely Columbian-Exchange event involving a new or more virulent strain, rather than a disease that had never existed in Europe at all.
The Great Pox: syphilis sweeps Europe (1494 onward)
In 1494, French troops under Charles VIII besieged Naples. Within months a horrifying new epidemic was tearing through the army, then through Europe. Soldiers developed pustular rashes, joint pain, neurological collapse, and disfiguring late-stage lesions. Italians called it "the French disease." The French called it "the Neapolitan disease." The Russians called it "the Polish disease." Almost every nation named it after a neighbor, which is its own commentary on how the world has always handled sexual illness.
The origin debate has run for 500 years. Genetic studies of treponemal DNA, including comparisons of pre- and post-1492 skeletal remains in Europe and the Americas, have given growing weight to the Columbian theory: a relative of Treponema pallidum circulated in the Americas before contact, and Columbus's crews carried a strain back to Europe that found a non-immune population and exploded. Other researchers argue the picture is more complicated, with treponemal disease present in pre-Columbian Europe in milder forms. What is not in dispute is the human toll. By 1500, the Great Pox had become the defining epidemic of Renaissance Europe, on a scale comparable to early HIV in the 20th century.
The Italians blamed the French. The French blamed the Neapolitans. The Polish blamed the Germans. The Russians blamed the Polish. The Ottomans called it the Christian disease. Naming a feared infection after the nearest stranger is one of the oldest patterns in epidemic history, and it tracks into the modern era: HIV faced the same kind of geographic and identity-based scapegoating in the 1980s, and so did COVID-19 in 2020. The pattern is so consistent that the WHO now formally avoids place-based names for new pathogens.
Brutal treatments before penicillin
For four centuries, treating syphilis meant choosing how you wanted to be poisoned. Mercury, taken orally, rubbed into the skin as ointment, or inhaled as fumes in heated chambers, was the dominant therapy from the early 1500s well into the 19th century. It caused severe nerve damage, tooth loss, kidney failure, and death. The grim joke of the era ran: "A night with Venus, a lifetime with Mercury." Guaiacum, a New World tropical wood boiled into a bitter potion, became briefly fashionable when mercury's harms were undeniable, then faded when it turned out not to work.
The first genuinely effective treatment arrived in 1910, when Paul Ehrlich and Sahachiro Hata introduced Salvarsan, an arsenic-based compound that could actually clear the syphilis spirochete from the body. It was difficult to administer and still toxic, but it was the first arrow in the antimicrobial era. The transformative breakthrough came in the 1940s, when Alexander Fleming's penicillin reached mass production. For the first time in recorded history, syphilis became something a doctor could simply cure with an injection.
Victorian stigma and the Contagious Diseases Acts
The 19th century stitched scientific progress to moral panic. Industrialization, colonialism, and the rapid growth of cities concentrated populations and reshaped sexual economies. Syphilis and gonorrhea spread, and so did the idea that infected women, specifically, were the source of contamination. The British Contagious Diseases Acts (1864, 1866, 1869) gave police powers to detain women suspected of sex work in garrison and port towns, force them to undergo invasive examinations, and confine them in "lock hospitals." Men were almost never examined.
Activists like Josephine Butler led the campaign to repeal the Acts, arguing correctly that they did almost nothing to reduce disease and a great deal to humiliate poor women. The Acts were repealed in 1886, but the underlying script of women as carriers, men as victims, and public health as a tool of social control would shape Western responses to sexual illness for the next century.
The Contagious Diseases Acts wrote one rule into law that has been hard to dislodge: when a sexual illness is rising, blame the women. That same script reappeared in the U.S. "American Plan" of the 1910s and 1920s, when authorities detained tens of thousands of women suspected of sex work for forced STI examination. It reappeared in the 1980s when sex workers (rather than the structural drivers of HIV transmission) were blamed for the early epidemic. Anyone using sexual-health policy to assign moral responsibility to one gender is reaching for an argument that has 160 years of failed precedent.
The diagnostic revolution and the ethics scandals it enabled
In 1905, Fritz Schaudinn and Erich Hoffmann finally identified the bacterium that causes syphilis. A year later, August von Wassermann developed the first usable blood test for the infection. For the first time, syphilis could be detected before its symptoms became unmistakable. The diagnostic revolution was real, and so was its dark side. Once you can test people, you can test them without consent.
Two episodes from the 20th century stand as moral landmarks. The Tuskegee Syphilis Study, run by the U.S. Public Health Service from 1932 to 1972, observed 399 Black men with untreated syphilis for forty years, withholding penicillin even after it became standard care, to chart the disease's natural progression. The Guatemala Syphilis Experiment (1946 to 1948) deliberately infected at least 1,308 prisoners, soldiers, mental-health patients, and sex workers with syphilis, gonorrhea, and chancroid without consent. The Tuskegee study was exposed in 1972 and prompted the modern framework of U.S. research ethics. The Guatemala study did not become public until 2010, when President Obama issued a formal apology and the U.S. Presidential Commission for the Study of Bioethical Issues opened a formal investigation that produced the 2011 report "Ethically Impossible."
More than 1 million curable sexually transmitted infections (STIs) are acquired every day worldwide in people 15–49 years old.
World wars, prophylaxis, and the penicillin breakthrough
Both world wars made STDs into a logistical military problem at industrial scale. The U.S. military issued "Pro Kits" containing chemical disinfectants and condoms, and ran graphic public-health campaigns warning recruits that an infection could disable a soldier as effectively as a bullet. Compulsory testing of enlistees became routine. In several theaters, militaries inspected or even ran brothels under medical surveillance, with consent rules that ranged from flimsy to nonexistent.
Penicillin changed the equation. By the mid-1940s, a single course of injections cured syphilis in most cases, with none of the disfigurement and death that had defined the disease for 450 years. Public health pivoted toward early detection, contact tracing, and rapid antibiotic treatment. There was a real victory here, and there was also a complacency. Many policymakers believed STDs were on their way to extinction. Funding for STI surveillance and clinics began a long decline that would haunt the late 20th century.
This article is published by stdrapidtestkits.com, which sells at-home STI testing kits. We recommend products based on whether they fit a reader's specific concern, not on commercial benefit. Where the situation calls for a clinic, we say so plainly.
HIV/AIDS rewrites the script (1980s and 1990s)
In June 1981, the U.S. CDC reported a cluster of unusual Pneumocystis pneumonia cases in previously healthy young men in Los Angeles. Within two years, researchers had identified HIV as the cause. Within a decade, AIDS had killed tens of thousands of people in the United States alone and millions worldwide. The disease hit communities, including gay men, IV-drug users, hemophiliacs, and Haitian immigrants, that political institutions were already inclined to ignore, which delayed a serious response by years.
HIV reshaped almost everything about how the world approached sexual disease. It forced safer-sex education into mainstream conversation. It pushed activist groups like ACT UP to invent the modern model of patient advocacy. It produced antiretroviral therapy, which by the mid-1990s converted HIV from a death sentence into a manageable lifelong condition for people who could access treatment. And it produced the U=U finding (Undetectable equals Untransmittable): a person on effective treatment with a sustained undetectable viral load cannot transmit HIV to a sexual partner.
The 21st-century resurgence
By 2000, many countries had grown used to thinking of bacterial STIs as solved problems. The data did not cooperate. CDC surveillance shows that reported U.S. cases of syphilis, gonorrhea, and chlamydia have climbed for most years since the early 2000s, with congenital syphilis, which transmits from a pregnant person to an infant, returning at rates not seen in decades. Rates are highest among populations that public-health systems already underserve: young people, Black and Indigenous communities, LGBTQ+ people, and people in rural counties without easy access to clinics.
The drivers are mostly structural: sustained underfunding of state and local public-health departments, the expansion of abstinence-only sex-education curricula in many U.S. school districts during the 2000s, fragmented healthcare access, persistent stigma that delays testing, and the closure of dedicated STD clinics during budget cycles. None of these are individual moral failings; they are policy choices, and they show up in the surveillance numbers within a few years of being made.
Of every figure in the modern STI surveillance picture, the one that should focus attention is congenital syphilis. The infection passes from a pregnant person to a fetus or newborn and can cause stillbirth, neonatal death, severe bone deformity, blindness, deafness, and lifelong neurological damage. Penicillin given to the pregnant parent prevents nearly all of it. A rising congenital syphilis rate, in other words, is not a statistic about a sexually transmitted disease; it is a statistic about prenatal care that did not happen. CDC surveillance has tracked congenital syphilis climbing back to rates that the U.S. had not seen in roughly thirty years.
Super gonorrhea and the antibiotic crisis
Neisseria gonorrhoeae is one of the most adaptable pathogens in human medicine. The bacterium continuously varies the proteins on its surface, which is part of why infection does not produce lasting immunity and why a vaccine has never quite arrived. That same shape-shifting ability has driven decades of antibiotic resistance. Penicillin worked in the 1940s. Tetracycline replaced it. Then ciprofloxacin. Then dual therapy with ceftriaxone plus azithromycin. Each line has been eroded.
In 2018, U.K. health authorities reported a case of gonorrhea resistant to every standard antibiotic in the treatment guideline. Similar multi-drug-resistant strains have since been documented in Europe, North America, and parts of Asia. The WHO's global priority pathogens list places cephalosporin-resistant and fluoroquinolone-resistant Neisseria gonorrhoeae in the high-priority category for which new antibiotics are urgently needed. New candidates like zoliflodacin are in late-stage trials, but the historical lesson is sharp: every antibiotic class so far has eventually lost ground, and the time between a drug's introduction and the first documented resistance is shrinking.
Digital dating and the at-home testing era
Tinder launched in 2012, Grindr in 2009, and the apps that followed restructured how a large fraction of the world meets sexual partners. Researchers have mapped how this affected partner-network density, which in turn affects how quickly an infection can move through a population. The pathogens predate the apps by millennia; what has changed is the speed and shape of transmission, with denser partner graphs accelerating spread through a population. Some platforms now nudge users toward disclosure, status badges, or testing reminders. Most users still do not engage with these features.
The same decade saw a quieter shift on the testing side. FDA-cleared at-home rapid tests and mail-in lab kits make it possible to screen for the most common STIs without setting foot in a clinic. The privacy this provides is not a luxury; for a non-trivial fraction of users, the choice is between an at-home test and no test at all. Access is still uneven. Rural counties, undocumented residents, and people without home addresses or stable mailing situations still face barriers that shipping a kit cannot solve. Still, the combination of telemedicine, rapid antigen and antibody assays, and confidential delivery has done more to democratize STI screening in 15 years than the previous 50 years of clinic-based public health.
What the long view actually teaches
Four thousand years of recorded STI history converge on a small list of stubborn lessons. Shame does not stop transmission; it delays testing, which accelerates it. Coerced public-health programs, from the Contagious Diseases Acts to the Guatemala study, breed a mistrust that lasts generations and undermines the legitimate programs that follow. Antibiotic resistance is not a freak event; it is the predictable result of how bacteria respond to selection pressure, and pretending otherwise has cost real lives. Access to honest education, confidential testing, and follow-up treatment is the variable that consistently matters most, across centuries and across continents.
None of those lessons require a moral framework that treats sex as the problem. They require a public-health framework that treats infection as the problem and people as competent adults who can act on accurate information.
If you are reading this and weighing whether to test, the historical pattern is unambiguous. The single intervention that has consistently reduced sexual disease across cultures, eras, and pathogens is making confidential, accurate testing easy and judgment-free. Whether that means a clinic, a telehealth visit, or an at-home rapid kit matters less than that the test actually happens. The shame is the obstacle. The test is the move.
Frequently asked questions
- Did Cleopatra actually have a sexually transmitted disease?
- There is no medical evidence that Cleopatra had an STD. The legends that suggest otherwise tell us more about how later eras imagined a powerful, sexually independent woman than about her actual health. What is documented is that the medicine of her era already recognized a category of illnesses that traveled with sex and was already trying, with limited tools, to treat them.
- Did Columbus's voyages bring syphilis to Europe?
- Most genetic and skeletal evidence supports the Columbian theory: a treponemal-disease relative was circulating in the Americas before 1492, and a strain reached a non-immune European population in the 1490s and exploded. Some researchers argue that milder treponemal disease was present in pre-Columbian Europe and that the post-1494 epidemic represents a hybrid or mutated form. The mainstream position remains that the Columbian Exchange was a major driver.
- How did people treat syphilis before penicillin?
- Mercury killed patients for four hundred years before arsenic offered a partial fix in 1910. Beyond that compressed arc, the practical detail worth knowing is that early treatments were often selected for visible effect (mercury-induced salivation, for example, was taken as proof the cure was working) rather than for clinical improvement, which is why so many patients died of the cure before the disease reached its terminal stages. Penicillin, available at scale from the mid-1940s, was the first treatment that was both effective and survivable.
- What was the Tuskegee Syphilis Study?
- Forty years of withholding treatment from 399 Black men who had syphilis, even after penicillin became standard care. The U.S. Public Health Service ran the program in Macon County, Alabama, from 1932 to 1972, ostensibly to chart the natural progression of the disease. A whistleblower disclosure in 1972 forced it to end and triggered the reforms (informed consent, institutional review boards, the Belmont Report) that now define U.S. research ethics.
- What was the Guatemala Syphilis Experiment?
- Deliberately infecting people without consent to test whether penicillin could prevent post-exposure infection. The same U.S. Public Health Service investigators who would later run Tuskegee, working with Guatemalan authorities and NIH funding, exposed prisoners, soldiers, mental-health patients, and sex workers to syphilis, gonorrhea, and chancroid between 1946 and 1948, infecting at least 1,308 of them. The records were uncovered by historian Susan Reverby and published in 2010, producing a Presidential apology and the U.S. Bioethics Commission's 2011 report "Ethically Impossible."
- Why are reported STD cases rising again in the 21st century?
- Congenital syphilis is the headline number: it has returned to U.S. rates not seen in roughly three decades, and unlike most STI metrics it cannot be explained by changes in sexual behavior because it tracks prenatal care. Once you read the rest of the surveillance picture through that lens, the structural drivers become legible: closures of dedicated STD clinics, abstinence-only sex education in many U.S. districts, fragmented healthcare access for low-income and uninsured populations, and stigma that delays testing all show up downstream.
- What is super gonorrhea and why does it matter?
- Strains of Neisseria gonorrhoeae that defeat the current first-line antibiotic regimen, ceftriaxone with or without azithromycin. The first fully resistant case surfaced in the U.K. in 2018; comparable cases have since appeared in North America, Europe, and Asia. The WHO's global priority pathogens list places cephalosporin-resistant gonorrhea in the high-priority category, meaning treatment options are narrowing while replacement antibiotics like zoliflodacin remain in late-stage trials.
- Are at-home STD tests reliable?
- Reputable at-home rapid tests use lateral-flow chemistry similar to in-clinic point-of-care assays, and the major brands publish independently validated sensitivity and specificity figures. Used after the correct window period and following the kit instructions, they are a useful screening tool. They are not a replacement for laboratory NAAT or PCR confirmation when a positive result needs to guide treatment, especially for gonorrhea given the antibiotic-resistance picture.
- U.S. Centers for Disease Control and Prevention. National STI surveillance data, including U.S. trends in syphilis, gonorrhea, and chlamydia, and congenital syphilis case counts.
- World Health Organization. Sexually transmitted infections fact sheet, including the global daily-new-case figure for curable STIs in people aged 15 to 49.
- U.S. Centers for Disease Control and Prevention. Gonorrhea topic page covering antimicrobial-resistance surveillance and current ceftriaxone-based treatment guidelines.
- World Health Organization. WHO publishes list of bacteria for which new antibiotics are urgently needed, placing cephalosporin-resistant and fluoroquinolone-resistant Neisseria gonorrhoeae in the Priority 2 (HIGH) tier.
- U.S. Centers for Disease Control and Prevention. Tuskegee Study and Health Benefit Program: history of the 1932 to 1972 study of untreated syphilis in 399 Black men in Macon County, Alabama, and the post-1972 reforms it produced.
- Rodriguez MA, Garcia R. First, Do No Harm: The US Sexually Transmitted Disease Experiments in Guatemala. American Journal of Public Health (NIH/PMC). Documents the 1946 to 1948 deliberate infection of at least 1,308 Guatemalan subjects with syphilis, gonorrhea, and chancroid, and the 2010 disclosure that prompted President Obama's apology.
